Previous close | 75.05 |
Open | 74.31 |
Bid | 73.28 x 1000 |
Ask | 0.00 x 1000 |
Day's range | 73.73 - 75.39 |
52-week range | 71.14 - 116.17 |
Volume | |
Avg. volume | 7,114,341 |
Market cap | 82.142B |
Beta (5Y monthly) | 0.96 |
PE ratio (TTM) | N/A |
EPS (TTM) | -4.54 |
Earnings date | 25 Jul 2022 - 29 Jul 2022 |
Forward dividend & yield | 0.32 (0.43%) |
Ex-dividend date | 07 Mar 2022 |
1y target est | 102.00 |
BOSTON, May 12, 2022--GE Healthcare has entered into an agreement to invest up to $50 million in Israeli start-up Pulsenmore, marking another strategic step forward in enabling precision health. This investment is aimed at accelerating global adoption of Pulsenmore’s homecare ultrasound solutions and will also support their goal to pursue U.S. FDA clearance and commercial expansion. In addition to its equity investment, GE Healthcare will also partner with Pulsenmore to distribute its products i
The industrial sector is expected to face the challenges stemming from rising interest rates, growing inflation levels and ongoing supply-chain disturbances in 2022.
CHICAGO & CHALFONT ST GILES, England, May 06, 2022--At the International Society for Magnetic Resonance in Medicine (ISMRM) 2022 Annual Meeting, GE Healthcare boasts the continued expansion of its pioneering deep learning image reconstruction solution, AIR Recon DL, to its tens of thousands of install base customers as an upgrade as well as with new purchases across its MR product portfolio. This marks a significant moment in the democratization of artificial intelligence (AI) and deep learning